logo

For the Inventor, By the Inventor

Lund, Sweden

Alligator Bioscience Ab


USPTO Granted Patents = 37

% Expired Patents = 43.2


Trademarks = 3

Forward Citations = 63

Loading Chart...
Loading Chart...

61 inventors (with patents filed for the assignee):

goldMedal Peter Ellmark (19 out of 19 patents)

silverMedal Christina Furebring (19 out of 19 patents)

bronzeMedal Laura Von Schantz (13 out of 13 patents)

4.  Sara Fritzell (10 out of 10 patents)

5.  Laura Varas (9 out of 9 patents)

6.  Niina Veitonmaki (9 out of 9 patents)

7.  Anna Sall (7 out of 7 patents)

8.  Per Norlen (6 out of 6 patents)

9.  Eva Maria Dahlen (6 out of 6 patents)

10.  Jessica Petersson (5 out of 5 patents)

11.  Roland Carlsson (5 out of 13 patents)

12.  Ann-Christin Malmborg Hager (5 out of 5 patents)

13.  Karin Enell Smith (4 out of 4 patents)

14.  Carl Borrebaeck (4 out of 4 patents)

15.  David Bienvenue (3 out of 7 patents)


Core Competencies:
Anti-CD40 Antibodies
Bispecific Polypeptides
Polypeptides
Combination Therapies
Oncofetal Antigens
CD137 Antibodies
Nucleic Acids
Protein Evolution
Medical Compositions
Affinity Variants

37 patents:

1. 12570759 - NOVEL POLYPEPTIDES (2026-03-10),
2. 12570753 - COMBINATION THERAPIES WITH ANTI CD40 ANTIBODIES (2026-03-10),
3. 12509526 - NOVEL ANTI-CD137 ANTIBODIES AND USES THEREOF (2025-12-30),
4. 12448465 - Peptides (2025-10-21),
5. 12415862 - Methods and compositions (2025-09-16),
6. 12173082 - Bispecific polypeptides against CD137 (2024-12-24),
7. 11873348 - Peptides (2024-01-16),
8. 11780928 - Polypeptides (2023-10-10),
9. 11725060 - Antigen binding proteins binding to 5T4 and 4-1BB and related compositions and methods (2023-08-15),
10. 11535678 - Anti-CD137 antibodies and uses thereof (2022-12-27),
11. 11312786 - Oncofetal antigen binding proteins and related compositions and methods (2022-04-26),
12. 11149090 - Combination therapies with anti CD40 antibodies (2021-10-19),
13. 11008396 - Polypeptides (2021-05-18),
14. 10774150 - Polypeptides (2020-09-15),
15. 10689454 - Anti-CD137 antibodies and uses thereof (2020-06-23),
Company Overview
Alligator Bioscience AB is a biotechnology company based in Lund, Sweden, specializing in the development of innovative immuno-oncology therapies. The company focuses on creating monoclonal antibodies and other biologics aimed at enhancing the immune system's ability to fight cancer. Alligator's research encompasses various aspects of cancer treatment, including targeted therapies and immune modulation, positioning it at the forefront of advancements in cancer immunotherapy.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Alligator Bioscience Ab USPTO Patent Assignee Logo
37 Patents

#16 in Lund

#189 in Sweden

#18,260 in the World

Lund, SE
Lund, Sweden

Alligator Bioscience Ab

Forward Citations = 63

61 inventors:

goldMedal Peter Ellmark (19 out of 19 patents)

silverMedal Christina Furebring (19 out of 19 patents)

bronzeMedal Laura Von Schantz (13 out of 13 patents)

4.  Sara Fritzell (10 out of 10 patents)

5.  Laura Varas (9 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Alligator Bioscience Ab. Retrieved from https://idiyas.com/company/alligator-bioscience-ab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…